WristArt Total Wrist Arthroplasty Implant First In Human Study

NCT ID: NCT06196528

Last Updated: 2024-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-02

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The WristArt implant will be implanted for the first time in humans' wrists

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wrist Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

WristArt implantation

Group Type EXPERIMENTAL

WristArt implant

Intervention Type DEVICE

implantation of the WristArt implant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WristArt implant

implantation of the WristArt implant

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects suffering from one the following conditions:

1. Osteoarthritis (OA) of the wrist joint due to various causes (age, trauma, Avascular Necrosis)
2. Rheumatoid arthritis of the wrist joint or other rheumatological diseases which destroy the wrist joint
3. Unrepairable previous intraarticular fractures of the distal radius, scaphoid or lunate bones of the wrist joint (i.e., historical fractures that were failed to fuse surgically)
4. Symptomatic congenital abnormalities around wrist joint such as carpal bones coalition, mild forms of Madelung's deformities etc.
5. Patients who underwent failed proximal row carpectomy, or failed partial carpal bones fusion
2. Patients who's their wrist x-ray shows no damage to the carpal bones that are not fused as part of the surgery
3. Patient Rated Wrist Evaluation Score (PRWE) at baseline is above 70 points out of 100
4. Visual Analog Pain Score (VAS) at baseline is above 70 points out of 100

Exclusion Criteria

1. Patients younger than 18 years old
2. Patients for whom bone growth did not complete yet
3. Paralytic hand patients
4. Patients with sensitivity to Titanium (ADD/CHANGE MATERIALS AS NEEDED)
5. Cerebral palsy patients with wrist joint contracture and loss of sensation in the hand
6. Low quality of capitate bone and/or excessively short capitate bone (≥50% destruction) due to various causes (AVN, comminuted fracture, lytic lesions, congenital etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fibioseq Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Oron

Role: PRINCIPAL_INVESTIGATOR

Kaplan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaplan Medical Center

Rehovot, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amir Oron, MD

Role: CONTACT

972-8-9441340

Shiran Rogof

Role: CONTACT

+97289441340

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amir Oron, MD

Role: primary

972-8-9441340

Shiran Rogof

Role: backup

972-8-9441340

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLN-0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post Market Clinical Follow-Up TOUCH® CMC 1
NCT06546306 ACTIVE_NOT_RECRUITING
Active Knee Prosthesis Study
NCT06700668 ACTIVE_NOT_RECRUITING NA